(NP (NP (NN Involvement)) (PP (IN of) (NP (JJ nuclear) (NN factor-kappa) (NN B) (NN activation))) (PP (IN in) (NP (NP (NN IgE) (NN synthesis)) (PP (IN in) (NP (JJ human) (NN B) (NNS cells))))) (. .))
(S (NP-SBJ (NP (JJ Nuclear) (NN factor-kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-))) (VP (VBZ is) (NP-PRD (NP (DT a) (NN transcription) (NN factor)) (SBAR (WHNP-62 (WDT that)) (S (NP-SBJ (-NONE- *T*-62)) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (NN consensus) (NN DNA) (NN sequence)) (PP (IN in) (NP (NP (DT the) (JJ cis-acting) (NNS elements)) (PP (IN of) (NP (JJ various) (NNS genes)))))))))))) (. .))
(S (SBAR (IN Although) (S (NP-SBJ (NN NF-kappa) (NN B)) (VP (VBZ activates) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ many) (NNS genes)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (ADJP-COOD (ADJP (JJ immune)) (CC and) (ADJP (JJ inflammatory))) (NNS responses)))))))))) (, ,) (NP-SBJ-63 (JJ little)) (VP (VBZ is) (VP (VBN known) (NP (-NONE- *-63)) (PP (IN about) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN NF-kappa) (NN B) (NN activation))) (PP (IN in) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN IgE) (NN synthesis))) (PP (IN in) (NP (JJ human) (NN B) (NNS cells))))))))) (. .))
(S (ADVP (RB Therefore)) (NP-SBJ (PRP we)) (ADVP-TMP (RB first)) (VP (VBD examined) (NP (NP (DT the) (NN participation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (NP (NN germline) (NN C) (NN epsilon) (NN transcription)) (PP (IN in) (NP (NP (DT a) (JJ human) (NN Burkitt) (NN lymphoma) (NN B) (NN cell) (NN line)) (, ,) (NP (NN DND39)))))))) (. .))
(S (NP-SBJ (NP (NN Stimulation)) (PP (IN of) (NP (NN DND39) (NNS cells))) (PP (IN with) (NP-COOD (NP (NN IL-4)) (CC or) (NP (JJ anti-CD40) (NP (NP (JJ monoclonal) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NN mAb)) (-RRB- -RRB-))))))) (VP-COOD (VP (VBD activated) (NP (NN phosphatidylinositol) (NN 3-kinase))) (CC and) (VP (ADVP (RB subsequently)) (VBD induced) (NP (NP (JJ nuclear) (NN expression)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (, ,) (SBAR (WHNP-64 (WDT which)) (S (NP-SBJ-65 (-NONE- *T*-64)) (VP (VBD was) (VP (VBN identified) (NP (-NONE- *-65)) (PP (IN by) (NP-LGS (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays)))))))))) (. .))
(S (NP-SBJ (NP (NP (NN n-Acetyl-L-cysteine)) (PRN (-LRB- -LRB-) (NP (NN NAC)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ potent) (NN antioxidant)) (, ,)) (VP (VBD blocked) (NP (NP (NN NF-kappa) (NN B) (NN activation)) (VP (VBN caused) (NP (-NONE- *)) (PP-COOD (PP (IN by) (NP-LGS (NN IL-4))) (CC and) (PP (IN by) (NP-LGS (JJ anti-CD40) (NN mAb))))))) (. .))
(S (SBAR (IN Although) (S (NP-SBJ (NP (NN inhibition)) (PP (IN of) (NP (JJ IL-4-driven) (NN germline) (NN C) (NN epsilon) (NN transcription))) (PP (IN by) (NP (NN NAC)))) (VP (VBD was) (RB not) (ADJP-PRD (JJ sufficient))))) (, ,) (NP-SBJ (DT the) (NN agent)) (ADVP (RB remarkably)) (VP (VBD diminished) (NP (NP (ADJP (JJ anti-CD40) (JJ mAb-mediated)) (NN up-regulation)) (PP (IN of) (NP (NN germline) (NN C) (NN epsilon) (NN transcription))))) (. .))
(S (ADVP-TMP (RB Second)) (, ,) (NP-SBJ (PRP we)) (VP (VBD studied) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN NAC))) (PP (IN on) (NP (NP (NN IgE) (NN synthesis)) (PP (IN in) (NP (NP (JJ human) (JJ normal) (NN B) (NNS cells)) (VP (VBN costimulated) (NP (-NONE- *)) (PP (IN with) (NP-COOD (NP (NN IL-4)) (CC and) (NP (JJ anti-CD40) (NN mAb))))))))))) (. .))
(S (NP-SBJ (NN NAC)) (VP (VBD was) (ADJP-PRD (JJ effective)) (PP (IN in) (S (NP-SBJ (-NONE- *)) (VP (VBG inhibiting) (NP (NP-COOD (NP (JJ mature) (NN C) (NN epsilon) (NN transcription)) (CC and) (NP (NN IgE) (NN synthesis))) (PP (IN in) (NP (DT the) (ADJP (NN T) (JJ cell-independent)) (NN culture) (NN system)))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ (NN NAC)) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB affect) (NP (NP (DT the) (JJ spontaneous) (NN production)) (PP (IN of) (NP (NN IgE))) (PP (IN by) (NP (JJ atopic) (NN B) (NNS cells)))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP-COOD (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ (NN NF-kappa) (NN B) (NN activity)) (VP (VBZ is) (ADVP (RB commonly)) (ADJP-PRD (JJ inducible) (PP (-NONE- *ICH*-105))) (PP (IN in) (NP (NN DND39) (NNS cells))) (PP-105 (IN by) (NP-COOD (NP (NN IL-4)) (CC and) (NP (JJ anti-CD40) (NN mAb)))))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ-106 (NP (NN NF-kappa) (NN B)) (ADJP (JJ sensitive) (PP (TO to) (NP (NN NAC))))) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (S (NP-SBJ (-NONE- *-106)) (VP (VBG regulating) (NP (NP (NN IgE) (NN synthesis)) (PP (IN in) (NP (NN B) (NNS cells))))))))))))) (. .))
